SE431161B - Sett att rena hepatit-b-antigen for anvendning sasom vaccin - Google Patents

Sett att rena hepatit-b-antigen for anvendning sasom vaccin

Info

Publication number
SE431161B
SE431161B SE7604818A SE7604818A SE431161B SE 431161 B SE431161 B SE 431161B SE 7604818 A SE7604818 A SE 7604818A SE 7604818 A SE7604818 A SE 7604818A SE 431161 B SE431161 B SE 431161B
Authority
SE
Sweden
Prior art keywords
hepatit
vaccin
antigen
clean
Prior art date
Application number
SE7604818A
Other languages
English (en)
Swedish (sv)
Other versions
SE7604818L (sv
Inventor
Ii A U Bertland
A A Tytell
G P Lampson
E B Buynak
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of SE7604818L publication Critical patent/SE7604818L/xx
Publication of SE431161B publication Critical patent/SE431161B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SE7604818A 1975-05-14 1976-04-27 Sett att rena hepatit-b-antigen for anvendning sasom vaccin SE431161B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/577,483 US4017360A (en) 1975-05-14 1975-05-14 Method for purifying hepatitis B antigen

Publications (2)

Publication Number Publication Date
SE7604818L SE7604818L (sv) 1976-11-15
SE431161B true SE431161B (sv) 1984-01-23

Family

ID=24308922

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7604818A SE431161B (sv) 1975-05-14 1976-04-27 Sett att rena hepatit-b-antigen for anvendning sasom vaccin

Country Status (15)

Country Link
US (1) US4017360A (xx)
JP (2) JPS51139619A (xx)
AU (1) AU504454B2 (xx)
BE (1) BE841811A (xx)
CA (1) CA1066191A (xx)
CH (1) CH629668A5 (xx)
CY (1) CY1034A (xx)
DE (1) DE2621276A1 (xx)
DK (1) DK145347C (xx)
ES (1) ES447858A1 (xx)
FR (1) FR2315947A1 (xx)
GB (1) GB1488774A (xx)
HK (1) HK86779A (xx)
NL (1) NL188621C (xx)
SE (1) SE431161B (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE437329B (sv) * 1975-03-14 1985-02-25 Community Blood Council Sett att ur blodserum framstella vaccin mot virushepatit
US4129646A (en) * 1976-11-02 1978-12-12 Merck & Co., Inc. Isolating hepatitis B Dane particles
GB1554811A (en) * 1977-02-23 1979-10-31 Merck & Co Inc Purifying hepatitis b surface antigen
US4217418A (en) * 1978-05-08 1980-08-12 Merck & Co., Inc. Recovery of small particles by flow centrifugation
ATE1882T1 (de) * 1978-05-08 1982-12-15 Merck & Co. Inc. Ein verfahren zur direkten extraktion von kleinen teilchen bis 50 nm aus einer proteinhaltigen fluessigkeit.
ZA792485B (en) * 1978-06-07 1980-06-25 New York Blood Center Inc Vaccine for active immunization containing hepatitis b surface and/or e-antigens
US4181713A (en) * 1978-10-30 1980-01-01 Merck & Co., Inc. Isolation of HBs Ag
US4395395A (en) * 1979-05-21 1983-07-26 The United States Of America As Represented By The Department Of Health And Human Services Detection of non-A, non-B hepatitis associated antigen
DE2935634C2 (de) * 1979-09-04 1981-12-10 Battelle-Institut E.V., 6000 Frankfurt Tiermodell zur Prüfung der Inaktivierung von Impfstoffen gegen Virushepatitis Typ B und zur Prüfung von Chemotherapeutika gegen Virushepatitis Typ A
FR2470795A1 (fr) * 1979-12-07 1981-06-12 Pasteur Institut Procede de purification de particules d'origine biologique, notamment de l'antigene de surface du virus de l'hepatite b (aghbs) et les produits obtenus
US4349539A (en) * 1980-08-15 1982-09-14 Merck & Co., Inc. Separation of hepatitis B surface antigen
PL133476B1 (en) * 1981-06-10 1985-06-29 Akad Medyczna Method of obtaining pure antigen hba from human serum
AU8746582A (en) * 1981-09-02 1983-03-10 Biogen N.V. Hepatitis b virus e type antigen
GB8321789D0 (en) * 1983-08-12 1983-09-14 Biogen Nv Vaccines and compositions against hepatitis
US4639371A (en) * 1984-10-02 1987-01-27 New York Blood Center, Inc. Hepatitis B antigenic compositions and vaccines against hepatitis B derived therefrom
JPS61158798A (ja) * 1984-12-28 1986-07-18 Japan Found Cancer Res Ｂ型肝炎ウイルス表面抗原の製造法
US5026828A (en) * 1987-02-27 1991-06-25 Merck & Co., Inc. Method of purifying recombinant pres-1/S-2/S/S hepatitis B antigen from yeast
JPS63246335A (ja) * 1987-09-17 1988-10-13 メルク　エンド　カムパニー　インコーポレーテツド 肝炎ｂ抗原
US5030720A (en) * 1988-09-01 1991-07-09 Merck & Co., Inc. Pres2+S hepatitis B vaccine derived from plasma

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636191A (en) * 1969-10-08 1972-01-18 Cancer Res Inst Vaccine against viral hepatitis and process
JPS5523254B2 (xx) * 1974-01-28 1980-06-21

Also Published As

Publication number Publication date
SE7604818L (sv) 1976-11-15
DE2621276C2 (xx) 1988-05-11
HK86779A (en) 1979-12-28
BE841811A (fr) 1976-11-16
NL7604429A (nl) 1976-11-16
DK145347C (da) 1983-05-02
JPS6345645B2 (xx) 1988-09-12
CY1034A (en) 1980-08-01
US4017360A (en) 1977-04-12
AU1361976A (en) 1977-11-10
DE2621276A1 (de) 1976-11-25
CA1066191A (en) 1979-11-13
GB1488774A (en) 1977-10-12
AU504454B2 (en) 1979-10-18
JPS51139619A (en) 1976-12-02
DK190776A (da) 1976-11-15
CH629668A5 (de) 1982-05-14
NL188621B (nl) 1992-03-16
DK145347B (da) 1982-11-01
JPS58180432A (ja) 1983-10-21
JPS6112894B2 (xx) 1986-04-10
NL188621C (nl) 1992-08-17
ES447858A1 (es) 1977-07-16
FR2315947A1 (fr) 1977-01-28
FR2315947B1 (xx) 1979-03-30

Similar Documents

Publication Publication Date Title
SE432247B (sv) Sett att framstella dihydro-cyklosporin c
SE433222B (sv) Sett att framstella modifierad polysackarid
BR7603030A (pt) Limpador de dentes
SE431161B (sv) Sett att rena hepatit-b-antigen for anvendning sasom vaccin
SE7606280L (sv) Sett att framstella etrar
SE7612532L (sv) Sett att framstella grundpalar
SE432212B (sv) Sett och anordning for att forma rorendar
SE420728B (sv) Sett att framstella piperazinyliminorifamyciner
SE427111B (sv) Sett att framstella pilokarpiniumsalter
SE7606484L (sv) Sett att framstella hoghallfasta cementkonglomerat
SE7611052L (sv) Sett att identifiera fluorescensemnen
SE433919B (sv) Sett vid bagsvetsning
AT337051B (de) Tarnvorrichtung
DK154944C (da) Rensemiddel
SE7508166L (sv) Rengoringsmedel
SE7610839L (sv) Sett att detektera hepatitantigen
SE398436C (sv) Sett for jordfri vextodling
SE420729B (sv) Sett att framstella substituerade piperazinyliminorifamyciner
SE430156B (sv) Sett att framstella 2-subst-1-(omega-aminoalkoxi)-bensener
SE7605650L (sv) Diskmaskin och sett for att driva densamma
SE427930B (sv) Sett att atervinna organotennhalogenider
SE7607171L (sv) Sett att framstella indolokinoliziner
SE433213B (sv) Sett att framstella 2 -fenyl-3-amino-benso/b/tiofenderivat
SE420731B (sv) Sett att framstella 5-androsten-17-on-derivat
SE7601564L (sv) Sett att framstella tabletter

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7604818-0

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7604818-0

Format of ref document f/p: F